Tech Company Financing Transactions

Santhera Pharmaceuticals AG Funding Round

On 12/17/2004, Santhera Pharmaceuticals AG raised $18 million in Series A funding from NGN Capital.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series A

NGN Capital (Lead Investor) (Georg Nebgen)

Proceeds Purpose
The capital raised in this round will allow us to advance the clinical and preclinical development of our novel therapies in the areas of neuromuscular and metabolic diseases.

Company Information

Company Status
Private & Independent
Mailing Address
Hohenrainstrasse 24
Pratteln, 4133
Email Address
The company is focused on the discovery, preclinical as well as clinical Santhera Pharmaceuticals is a Swiss biopharmaceutical company focusing on the discovery, development and marketing of small molecule pharmaceutical products for the treatment of neuromuscular diseases.
Santhera Pharmaceuticals AG LinkedIn Company Profile
Social Media
Santhera Pharmaceuticals AG Company Twitter Account
Company News
Santhera Pharmaceuticals AG News
Santhera Pharmaceuticals AG on Facebook
Santhera Pharmaceuticals AG on YouTube

Management Team

Email & Social
Elmar Schnee
  Elmar Schnee LinkedIn Profile  Elmar Schnee Twitter Account  Elmar Schnee News  Elmar Schnee on Facebook
Chief Executive Officer
Thomas Meier
  Thomas Meier LinkedIn Profile  Thomas Meier Twitter Account  Thomas Meier News  Thomas Meier on Facebook
Chief Financial Officer
Christoph Rentsch
  Christoph Rentsch LinkedIn Profile  Christoph Rentsch Twitter Account  Christoph Rentsch News  Christoph Rentsch on Facebook
Chief Medical Officer
Kristina Nygren
  Kristina Nygren LinkedIn Profile  Kristina Nygren Twitter Account  Kristina Nygren News  Kristina Nygren on Facebook
VP - Bus. Development
Günther Metz
   Günther Metz LinkedIn Profile   Günther Metz Twitter Account   Günther Metz News   Günther Metz on Facebook
VP - General Counsel
Oliver Strub
  Oliver Strub LinkedIn Profile  Oliver Strub Twitter Account  Oliver Strub News  Oliver Strub on Facebook



Browse more venture capital transactions:

Prev: 12/16/2004: Splunk venture capital transaction
Next: 12/20/2004: BiPar Sciences venture capital transaction


Share this article


About Database of VC Transactions

We report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary